PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34336031-0	2021	Knockdown of microRNA-130b improves doxorubicin sensitivity in bladder urothelial carcinoma by negatively regulating cylindromatosis expression.	Doxorubicin	36-47	microRNA 130b	Homo sapiens	13-26	
34336031-0	2021	Knockdown of microRNA-130b improves doxorubicin sensitivity in bladder urothelial carcinoma by negatively regulating cylindromatosis expression.	Doxorubicin	36-47	CYLD lysine 63 deubiquitinase	Homo sapiens	117-132	
34336031-7	2021	Results: Our study found that miR-130b was up-regulated in doxorubicin-insensitive BUC tissues and cell lines, and its high expression was negatively related to doxorubicin sensitivity in BUC.	Doxorubicin	59-70	microRNA 130b	Homo sapiens	30-38	
34336031-7	2021	Results: Our study found that miR-130b was up-regulated in doxorubicin-insensitive BUC tissues and cell lines, and its high expression was negatively related to doxorubicin sensitivity in BUC.	Doxorubicin	161-172	microRNA 130b	Homo sapiens	30-38	
34336031-8	2021	The miR-130b knockdown reduced the IC50 of doxorubicin and improved doxorubicin sensitivity of J82/Dox and T24/Dox cells.	Doxorubicin	43-54	microRNA 130b	Homo sapiens	4-12	
34336031-8	2021	The miR-130b knockdown reduced the IC50 of doxorubicin and improved doxorubicin sensitivity of J82/Dox and T24/Dox cells.	Doxorubicin	68-79	microRNA 130b	Homo sapiens	4-12	
34336031-8	2021	The miR-130b knockdown reduced the IC50 of doxorubicin and improved doxorubicin sensitivity of J82/Dox and T24/Dox cells.	Doxorubicin	99-102	microRNA 130b	Homo sapiens	4-12	
34336031-8	2021	The miR-130b knockdown reduced the IC50 of doxorubicin and improved doxorubicin sensitivity of J82/Dox and T24/Dox cells.	Doxorubicin	111-114	microRNA 130b	Homo sapiens	4-12	
34336031-11	2021	Knockdown of CYLD reversed miR-130b"s regulatory roles in doxorubicin sensitivity in J82/Dox and T24/Dox cells.	Doxorubicin	58-69	CYLD lysine 63 deubiquitinase	Homo sapiens	13-17	
34336031-11	2021	Knockdown of CYLD reversed miR-130b"s regulatory roles in doxorubicin sensitivity in J82/Dox and T24/Dox cells.	Doxorubicin	58-69	microRNA 130b	Homo sapiens	27-35	
34336031-11	2021	Knockdown of CYLD reversed miR-130b"s regulatory roles in doxorubicin sensitivity in J82/Dox and T24/Dox cells.	Doxorubicin	89-92	CYLD lysine 63 deubiquitinase	Homo sapiens	13-17	
34336031-11	2021	Knockdown of CYLD reversed miR-130b"s regulatory roles in doxorubicin sensitivity in J82/Dox and T24/Dox cells.	Doxorubicin	89-92	microRNA 130b	Homo sapiens	27-35	
34336031-11	2021	Knockdown of CYLD reversed miR-130b"s regulatory roles in doxorubicin sensitivity in J82/Dox and T24/Dox cells.	Doxorubicin	101-104	CYLD lysine 63 deubiquitinase	Homo sapiens	13-17	
34336031-11	2021	Knockdown of CYLD reversed miR-130b"s regulatory roles in doxorubicin sensitivity in J82/Dox and T24/Dox cells.	Doxorubicin	101-104	microRNA 130b	Homo sapiens	27-35	
34336031-12	2021	Conclusions: High expression of miR-130b is negatively related to doxorubicin sensitivity in BUC, and knockdown of miR-130b improves doxorubicin sensitivity in BUC by negatively regulating CYLD expression.	Doxorubicin	66-77	microRNA 130b	Homo sapiens	32-40	
34336031-12	2021	Conclusions: High expression of miR-130b is negatively related to doxorubicin sensitivity in BUC, and knockdown of miR-130b improves doxorubicin sensitivity in BUC by negatively regulating CYLD expression.	Doxorubicin	133-144	microRNA 130b	Homo sapiens	115-123	
34336031-12	2021	Conclusions: High expression of miR-130b is negatively related to doxorubicin sensitivity in BUC, and knockdown of miR-130b improves doxorubicin sensitivity in BUC by negatively regulating CYLD expression.	Doxorubicin	133-144	CYLD lysine 63 deubiquitinase	Homo sapiens	189-193